Reserved area: Log in


SILAB participated in the 16th congress of the E²BRN (European Epidermal Barrier Research Network), which took place on September 27-28, 2018 in Toulouse (France). It allowed European scientific experts of the skin barrier function to exchange on this subject.

SILAB’s R&D department presented its research work which enabled to create in vitro 3D skin models having the characteristics of an atopic skin. These models supported the development of AD-RESYL®, a purified natural active ingredient, specifically designed to prevent the clinical signs of atopic dermatitis and prolong the periods of remission, as relay of corticosteroid therapy.